Search
Browse
Statistics
Feeds

Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease

[thumbnail of 17738oa.pdf]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
4MB

Item Type:Article
Title:Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease
Creators: Arnoux, I. ORCID logoORCID: https://orcid.org/0000-0003-4530-9944, Willam, M., Griesche, N., Krummeich, J., Watari, H., Offermann, N., Weber, S., Narayan Dey, P., Chen, C., Monteiro, O., Buettner, S., Meyer, K., Bano, D., Radyushkin, K., Langston, R., Lambert, J.J., Wanker, E. ORCID logoORCID: https://orcid.org/0000-0001-8072-1630, Methner, A. ORCID logoORCID: https://orcid.org/0000-0002-8774-0057, Krauss, S., Schweiger, S. and Stroh, A. ORCID logoORCID: https://orcid.org/0000-0001-9410-4086
Abstract:Catching primal functional changes in early, 'very far from disease onset' (VFDO) stages of Huntington's disease is likely to be the key to a successful therapy. Focusing on VFDO stages, we assessed neuronal microcircuits in premanifest Hdh150 knock-in mice. Employing in vivo two-photon Ca(2+) imaging, we revealed an early pattern of circuit dysregulation in the visual cortex- one of the first regions affected in premanifest Huntington's disease - characterized by an increase in activity, an enhanced synchronicity and hyperactive neurons. These findings are accompanied by aberrations in animal behavior. We furthermore show that the anti-diabetic drug metformin diminishes aberrant Huntingtin protein load and fully restores both, early network activity patterns and behavioral aberrations. This network-centered approach reveals a critical window of vulnerability far before clinical manifestation and establishes metformin as a promising candidate for a chronic therapy starting early in premanifest Huntington's disease pathogenesis long before the onset of clinical symptoms.
Keywords:Huntington Disease, In Vivo Calcium Imaging, Cortical Microcircuits, Neuronal Hyperactivity, Metformin, Animals, Caenorhabditis elegans
Source:eLife
ISSN:2050-084X
Publisher:eLife Sciences Publications
Volume:7
Page Range:e38744
Date:4 September 2018
Official Publication:https://doi.org/10.7554/eLife.38744
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library